Danimer Scientific, Inc. SEC Filings

Filed On	Filing
15 May 2025	SCHEDULE 13G/A
18 Mar 2025	8-K: Bankruptcy or Receivership; Triggering Events That Accelerate a Financial Obligation +1 more
28 Feb 2025	8-K: Entry into a Material Definitive Agreement
14 Feb 2025	SCHEDULE 13G/A
11 Feb 2025	8-K: Entry into a Material Definitive Agreement; Triggering Events That Accelerate a Financial Obligation
10 Feb 2025	Form 4: Hajost Michael A, Chief Financial Officer Received 859 shares by exercise or conversion · Gave up 301 shares to cover exercise price or tax ($355)
21 Jan 2025	Form 4: Moody David Jesse, Director Received 646 shares by exercise or conversion
17 Jan 2025	25-NSE
03 Jan 2025	Form 4: Croskrey Stephen, Director Granted 1,125 Restricted Stock Units
31 Dec 2024	424B3
31 Dec 2024	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule; Regulation FD Disclosure
17 Dec 2024	424B3
17 Dec 2024	8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +3 more
13 Dec 2024	424B3
13 Dec 2024	8-K: Departure/Election of Directors or Officers; Compensation
13 Dec 2024	424B3
12 Dec 2024	8-K: Departure/Election of Directors or Officers; Compensation
03 Dec 2024	424B3
03 Dec 2024	8-K: Departure/Election of Directors or Officers; Compensation
19 Nov 2024	424B3

Comments